Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerAI sign LanguageOpen
VIPCreated with Sketch.

Chinese Expert Consensus on Immunotherapy for Hepatocellular Carcinoma (2021 Edition).

Yu Yang,Juxian Sun,Mengchao Wu,Wan Yee Lau, Shusen Zheng,Xue-Hao Wang,Xiaoping Chen,Jia Fan,Jiahong Dong,Jianqiang Cai,Minshan Chen,Yongjun Chen,Zhangjun Cheng,Chaoliu Dai,Jianzhen Shan,Cheng-You Du,Chihua Fang,Heping Hu,Zhili Ji,Weidong Jia,Gong Li,Jing Li,Jiangtao Li,Chang Liu,Fubao Liu,Yong Ma,Yilei Mao,Zuoxing Niu,Jie Shen,Jie Shi,Xuetao Shi,Wenjie Song,Hui-Chuan Sun,Guang Tan,Ran Tao,Xiaohu Wang,Tianfu Wen,Liqun Wu,Jinglin Xia,Bang-De Xiang,Maolin Yan,Mingang Ying,Ling Zhang,Xuewen Zhang,Zhao Chong Zeng,Yubao Zhang,Zhiwei Zhang,Jie Zhou,Cuncai Zhou,Jun Zhou,Ledu Zhou,Xinmin Zhou,Ji Zhu,Zhenyu Zhu,Qi Zhang,Qiu Li,Shuqun Cheng

Liver cancer（2022）

Cited 9|Views75
No score
Abstract
The consensus contained 17 recommendations, including the preferred regimen for first- and second-line immunotherapy, evaluation and monitoring before/during/after treatment, management of complications, precautions for special patients, and potential population for immunotherapy.
More
Translated text
Key words
Consensus,Hepatocellular carcinoma,Immune checkpoint inhibitors
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined